Psychometric properties of the Itch Numeric Rating Scale in patients with moderate‐to‐severe plaque psoriasis
Open Access
- 8 May 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 175 (1), 157-162
- https://doi.org/10.1111/bjd.14464
Abstract
Itching is a profoundly distressing symptom for many patients with psoriasis, but it has not been rigorously studied using validated tools for this condition. This study investigated the psychometric properties of the Itch Numeric Rating Scale (Itch NRS), a single-item patient-reported outcome (PRO) measuring the worst itching severity due to psoriasis in the past 24 h. Using disease-specific clinician-rated and PRO data from one phase II and three phase III randomized clinical studies of subjects with moderate-to-severe plaque psoriasis, the Itch NRS was evaluated for test-retest reliability, construct validity and responsiveness. A responder definition was explored using anchor- and distribution-based methods. Test-retest reliability analyses supported the reproducibility of the measure (intraclass correlation coefficient range 0·71-0·74). To support the construct validity of the Itch NRS, large cross-sectional correlations with the Dermatology Life Quality Index (DLQI) Symptoms and Feelings domain (r ≥ 0·60 at baseline and r ≥ 0·80 at week 12) supported a priori hypotheses, while large correlations (r ≥ 0·71) between changes in Itch NRS scores and changes in DLQI Symptoms and Feelings domain scores from baseline to week 12 established responsiveness. A 4-point change was optimal for demonstrating a level of clinically meaningful improvement in itch severity after 12 weeks of treatment, which corresponds with marked clinical improvements in plaque psoriasis. The Itch NRS demonstrated sufficient reliability, validity and responsiveness, and appropriate interpretation standards for evaluating change over time in itch severity among patients with moderate-to-severe plaque psoriasis when validated using clinical trial data for this condition.Funding Information
- Eli Lilly and Company
This publication has 21 references indexed in Scilit:
- Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trialBritish Journal of Dermatology, 2014
- Clinical and psychological characteristics of patients with psoriasis reporting various frequencies of pruritusInternational Journal of Dermatology, 2013
- The Psoriasis Symptom Diary: development and content validity of a novel patient‐reported outcome instrumentInternational Journal of Dermatology, 2013
- Pruritus is an Important Factor Negatively Influencing the Well-being of Psoriatic PatientsActa Dermato-Venereologica, 2010
- The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groupsHealth and Quality of Life Outcomes, 2009
- Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologicsJournal of the American Academy of Dermatology, 2008
- Patients’ perspective of pruritus in chronic plaque psoriasis: a questionnaire‐based studyJournal of the European Academy of Dermatology and Venereology, 2008
- Prevalence of physical symptoms of itch, pain and fatigue in patients with skin diseases in general practiceBritish Journal of Dermatology, 2007
- Prevalence of symptoms experienced by patients with different clinical types of psoriasisBritish Journal of Dermatology, 2004
- Treatment of PsoriasisThe New England Journal of Medicine, 1995